Printer Friendly
The Free Library
14,495,914 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kobayashi Pharmaceutical, Aloe Pharmaceutical to Conclude Share Transfer Agreement.


Tokyo, Japan, June 23, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Kobayashi Pharmaceutical has signed a share transfer agreement with Aloe Pharmaceutical.

Under the agreement, Kobayashi Pharmaceutical will acquire all shares of Aloe Pharmaceutical by July 31. Based in Shizuoka prefecture, Aloe Pharmaceutical has specialized in research on aloe vera aloe vera
n.
1. A species of aloe (Aloe vera) native to the Mediterranean region.

2. The mucilaginous juice or gel obtained from the leaves of this plant, used in pharmaceutical preparations for its soothing and healing
 since the Company's founding in 1938. Aloe Pharmaceutical markets Mamiya Aloe Ointment ointment /oint·ment/ (oint´ment) a semisolid preparation for external application to the skin or mucous membranes, usually containing a medicinal substance.

oint·ment
n.
, the over-the-counter drug over-the-counter drug A therapeutic agent that does not require a prescription, which the FDA feels can be safely self-prescribed by non-physicians. Cf Prescription drug, Under-the-counter.  that contains aloe extract as a main ingredient.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 23, 2006
Words:78
Previous Article:Toyama Chemical Launches Phase I Clinical Trials of Anti-rheumatic Agent T-5224.
Next Article:Riken Discovers New Mechanism for Controlling Allergic Reactions.



Related Articles
Hand sanitizer. (Product Marketplace).(Brief Article)
UNIGEN/UNIV. OF PANAMA SIGN PLANT COLLECTION PACT.
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2005.
Takeda Pharmaceutical Transfers All BASF Takeda Vitamin Shares to BASF Japan.
Kobayashi Pharmaceutical Announces Results for the Third Quarter Ended December 31, 2005.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the First Quarter Ended June 30, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the First Half Ended Sept. 30, 2006.
Kobayashi Pharmaceutical Announces Results for the Third Quarter Ended December 31, 2006.
Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2007.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles